The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Insulin Needle-free Syringes-Global Market Insights and Sales Trends 2024

Insulin Needle-free Syringes-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1866647

No of Pages : 103

Ask Your Query
Synopsis
Needle-free nozzle is the key feature of the system. By pressing insulin through the nozzle orifice, a fine stream of insulin is created that easily penetrates the skin. Subsequently, the insulin follows the path of least resistance, spreading evenly in the subcutaneous layer.
The global Insulin Needle-free Syringes market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Needle-free Syringes in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Insulin Needle-free Syringes market. Powder Injections, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid Injections segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Insulin Needle-free Syringes market, driven by demand from China, the second largest economy with some signs of stabilising, the Insulin Needle-free Syringes market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Needle-free Syringes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Needle-free Syringes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Needle-free Syringes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Needle-free Syringes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Needle-free Syringes covered in this report include Zogenix, Inovio, Glide Pharma, Akra Dermojet, Crossject Medical Technology, Injex Pharma, Eternity Healthcare, Antares Pharma and Valeritas, etc.
The global Insulin Needle-free Syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zogenix
Inovio
Glide Pharma
Akra Dermojet
Crossject Medical Technology
Injex Pharma
Eternity Healthcare
Antares Pharma
Valeritas
Medical International Technologies
Penjet
PharmaJet
National Medical Products
Activa Brand Products
Global Insulin Needle-free Syringes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Needle-free Syringes market, Segment by Type:
Powder Injections
Liquid Injections
Global Insulin Needle-free Syringes market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Needle-free Syringes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Needle-free Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Insulin Needle-free Syringes Market Overview
1.1 Insulin Needle-free Syringes Product Overview
1.2 Insulin Needle-free Syringes Market Segment by Type
1.2.1 Powder Injections
1.2.2 Liquid Injections
1.3 Global Insulin Needle-free Syringes Market Size by Type
1.3.1 Global Insulin Needle-free Syringes Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Needle-free Syringes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Needle-free Syringes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Needle-free Syringes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Needle-free Syringes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Needle-free Syringes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Needle-free Syringes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Needle-free Syringes Sales Breakdown by Type (2018-2023)
2 Global Insulin Needle-free Syringes Market Competition by Company
2.1 Global Top Players by Insulin Needle-free Syringes Sales (2018-2023)
2.2 Global Top Players by Insulin Needle-free Syringes Revenue (2018-2023)
2.3 Global Top Players by Insulin Needle-free Syringes Price (2018-2023)
2.4 Global Top Manufacturers Insulin Needle-free Syringes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Needle-free Syringes Market Competitive Situation and Trends
2.5.1 Insulin Needle-free Syringes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Needle-free Syringes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Needle-free Syringes as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Needle-free Syringes Market
2.8 Key Manufacturers Insulin Needle-free Syringes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Needle-free Syringes Status and Outlook by Region
3.1 Global Insulin Needle-free Syringes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Needle-free Syringes Historic Market Size by Region
3.2.1 Global Insulin Needle-free Syringes Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Needle-free Syringes Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Needle-free Syringes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Needle-free Syringes Forecasted Market Size by Region
3.3.1 Global Insulin Needle-free Syringes Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Needle-free Syringes Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Needle-free Syringes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Needle-free Syringes by Application
4.1 Insulin Needle-free Syringes Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Insulin Needle-free Syringes Market Size by Application
4.2.1 Global Insulin Needle-free Syringes Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Needle-free Syringes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Needle-free Syringes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Needle-free Syringes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Needle-free Syringes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Needle-free Syringes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Needle-free Syringes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Needle-free Syringes Sales Breakdown by Application (2018-2023)
5 North America Insulin Needle-free Syringes by Country
5.1 North America Insulin Needle-free Syringes Historic Market Size by Country
5.1.1 North America Insulin Needle-free Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Needle-free Syringes Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Needle-free Syringes Sales in Value by Country (2018-2023)
5.2 North America Insulin Needle-free Syringes Forecasted Market Size by Country
5.2.1 North America Insulin Needle-free Syringes Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Needle-free Syringes Sales in Value by Country (2024-2029)
6 Europe Insulin Needle-free Syringes by Country
6.1 Europe Insulin Needle-free Syringes Historic Market Size by Country
6.1.1 Europe Insulin Needle-free Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Needle-free Syringes Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Needle-free Syringes Sales in Value by Country (2018-2023)
6.2 Europe Insulin Needle-free Syringes Forecasted Market Size by Country
6.2.1 Europe Insulin Needle-free Syringes Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Needle-free Syringes Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Needle-free Syringes by Region
7.1 Asia-Pacific Insulin Needle-free Syringes Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Needle-free Syringes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Needle-free Syringes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Needle-free Syringes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Needle-free Syringes Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Needle-free Syringes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Needle-free Syringes Sales in Value by Region (2024-2029)
8 Latin America Insulin Needle-free Syringes by Country
8.1 Latin America Insulin Needle-free Syringes Historic Market Size by Country
8.1.1 Latin America Insulin Needle-free Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Needle-free Syringes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Needle-free Syringes Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Needle-free Syringes Forecasted Market Size by Country
8.2.1 Latin America Insulin Needle-free Syringes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Needle-free Syringes Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Needle-free Syringes by Country
9.1 Middle East and Africa Insulin Needle-free Syringes Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Needle-free Syringes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Needle-free Syringes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Needle-free Syringes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Needle-free Syringes Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Needle-free Syringes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Needle-free Syringes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Zogenix
10.1.1 Zogenix Company Information
10.1.2 Zogenix Introduction and Business Overview
10.1.3 Zogenix Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zogenix Insulin Needle-free Syringes Products Offered
10.1.5 Zogenix Recent Development
10.2 Inovio
10.2.1 Inovio Company Information
10.2.2 Inovio Introduction and Business Overview
10.2.3 Inovio Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Inovio Insulin Needle-free Syringes Products Offered
10.2.5 Inovio Recent Development
10.3 Glide Pharma
10.3.1 Glide Pharma Company Information
10.3.2 Glide Pharma Introduction and Business Overview
10.3.3 Glide Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glide Pharma Insulin Needle-free Syringes Products Offered
10.3.5 Glide Pharma Recent Development
10.4 Akra Dermojet
10.4.1 Akra Dermojet Company Information
10.4.2 Akra Dermojet Introduction and Business Overview
10.4.3 Akra Dermojet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Akra Dermojet Insulin Needle-free Syringes Products Offered
10.4.5 Akra Dermojet Recent Development
10.5 Crossject Medical Technology
10.5.1 Crossject Medical Technology Company Information
10.5.2 Crossject Medical Technology Introduction and Business Overview
10.5.3 Crossject Medical Technology Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Crossject Medical Technology Insulin Needle-free Syringes Products Offered
10.5.5 Crossject Medical Technology Recent Development
10.6 Injex Pharma
10.6.1 Injex Pharma Company Information
10.6.2 Injex Pharma Introduction and Business Overview
10.6.3 Injex Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Injex Pharma Insulin Needle-free Syringes Products Offered
10.6.5 Injex Pharma Recent Development
10.7 Eternity Healthcare
10.7.1 Eternity Healthcare Company Information
10.7.2 Eternity Healthcare Introduction and Business Overview
10.7.3 Eternity Healthcare Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Eternity Healthcare Insulin Needle-free Syringes Products Offered
10.7.5 Eternity Healthcare Recent Development
10.8 Antares Pharma
10.8.1 Antares Pharma Company Information
10.8.2 Antares Pharma Introduction and Business Overview
10.8.3 Antares Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Antares Pharma Insulin Needle-free Syringes Products Offered
10.8.5 Antares Pharma Recent Development
10.9 Valeritas
10.9.1 Valeritas Company Information
10.9.2 Valeritas Introduction and Business Overview
10.9.3 Valeritas Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Valeritas Insulin Needle-free Syringes Products Offered
10.9.5 Valeritas Recent Development
10.10 Medical International Technologies
10.10.1 Medical International Technologies Company Information
10.10.2 Medical International Technologies Introduction and Business Overview
10.10.3 Medical International Technologies Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medical International Technologies Insulin Needle-free Syringes Products Offered
10.10.5 Medical International Technologies Recent Development
10.11 Penjet
10.11.1 Penjet Company Information
10.11.2 Penjet Introduction and Business Overview
10.11.3 Penjet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Penjet Insulin Needle-free Syringes Products Offered
10.11.5 Penjet Recent Development
10.12 PharmaJet
10.12.1 PharmaJet Company Information
10.12.2 PharmaJet Introduction and Business Overview
10.12.3 PharmaJet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.12.4 PharmaJet Insulin Needle-free Syringes Products Offered
10.12.5 PharmaJet Recent Development
10.13 National Medical Products
10.13.1 National Medical Products Company Information
10.13.2 National Medical Products Introduction and Business Overview
10.13.3 National Medical Products Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.13.4 National Medical Products Insulin Needle-free Syringes Products Offered
10.13.5 National Medical Products Recent Development
10.14 Activa Brand Products
10.14.1 Activa Brand Products Company Information
10.14.2 Activa Brand Products Introduction and Business Overview
10.14.3 Activa Brand Products Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Activa Brand Products Insulin Needle-free Syringes Products Offered
10.14.5 Activa Brand Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Needle-free Syringes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Needle-free Syringes Industrial Chain Analysis
11.4 Insulin Needle-free Syringes Market Dynamics
11.4.1 Insulin Needle-free Syringes Industry Trends
11.4.2 Insulin Needle-free Syringes Market Drivers
11.4.3 Insulin Needle-free Syringes Market Challenges
11.4.4 Insulin Needle-free Syringes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Needle-free Syringes Distributors
12.3 Insulin Needle-free Syringes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock